Diary Bunda, an app that helps mothers keep track of their pregnancies, was purchased by Indonesia-based Alodokter from Japan-based Marubeni Corporation for an undisclosed sum.
According to VentureCap Insights, which monitors regulatory filings in Singapore, Alodokter has also raised US $6 million from Optima Health. Sentara, a significant US-based healthcare provider, offers health insurance through its Optima Health division.
Companies may, however, raise debt, which, unless converted to equity, is not disclosed in regulatory filings. As a result, the financial information provided in filings might not be accurate.
Diary Bunda offers personalized pregnancy and infant growth tracking, as well as educational materials and discussion boards, to Indonesian mothers.
“With Diary Bunda under our umbrella, we can offer an enhanced service to millions of mothers and expectant women, giving them the vital healthcare information and services they need at their fingertips,” Suci Arumsari, president director of Alodokter, said in a statement.
Alodokter currently offers a variety of integrated healthtech services, such as telemedicine, e-pharmacy, appointment scheduling, digital health insurance, and medical content.
The business earlier this year released Alni, a virtual assistant for doctors that operates through chat. It prescreens patients and offers prediagnosis suggestions to Alodokter’s telemedicine doctors using conversational AI.
MDI Ventures and Samsung Ventures contributed an undisclosed sum to the healthtech company’s 2021 funding. Alodokter had also received prior investments from Sequis Life, SoftBank Ventures Asia, and Golden Gate Ventures.